BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,812,000 | -0.1% | 45,063 | -3.7% | 0.01% | +11.1% |
| Q2 2022 | $6,819,000 | -16.9% | 46,796 | -32.4% | 0.01% | 0.0% |
| Q1 2022 | $8,208,000 | -9.4% | 69,226 | +5.3% | 0.01% | 0.0% |
| Q4 2021 | $9,062,000 | +0.3% | 65,760 | +1.1% | 0.01% | -10.0% |
| Q3 2021 | $9,036,000 | +60.8% | 65,049 | +12.3% | 0.01% | +66.7% |
| Q2 2021 | $5,621,000 | +50.6% | 57,905 | +6.0% | 0.01% | +50.0% |
| Q1 2021 | $3,732,000 | -22.1% | 54,607 | -2.3% | 0.00% | -20.0% |
| Q4 2020 | $4,790,000 | +28.8% | 55,887 | -2.3% | 0.01% | 0.0% |
| Q3 2020 | $3,718,000 | -8.9% | 57,187 | +2.5% | 0.01% | 0.0% |
| Q2 2020 | $4,079,000 | +151.9% | 55,787 | +17.2% | 0.01% | +150.0% |
| Q1 2020 | $1,619,000 | -32.7% | 47,587 | +7.7% | 0.00% | -33.3% |
| Q4 2019 | $2,406,000 | +20.4% | 44,202 | -7.7% | 0.00% | 0.0% |
| Q3 2019 | $1,998,000 | +5.4% | 47,902 | +10.6% | 0.00% | +50.0% |
| Q2 2019 | $1,896,000 | +1.7% | 43,302 | +19.6% | 0.00% | 0.0% |
| Q1 2019 | $1,864,000 | +47.7% | 36,216 | +6.2% | 0.00% | 0.0% |
| Q4 2018 | $1,262,000 | -7.7% | 34,116 | -6.3% | 0.00% | 0.0% |
| Q3 2018 | $1,367,000 | -5.0% | 36,413 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,439,000 | +42.8% | 36,413 | -7.0% | 0.00% | +100.0% |
| Q1 2018 | $1,008,000 | +248.8% | 39,148 | +265.9% | 0.00% | – |
| Q4 2017 | $289,000 | -59.3% | 10,700 | -43.7% | 0.00% | -100.0% |
| Q3 2017 | $710,000 | +49.5% | 18,994 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $475,000 | – | 18,994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |